$Health-related quality of life (HRQoL) with enasidenib versus conventional care regimens in older patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia (R/R AML)$

Health-related quality of life (HRQoL) with enasidenib versus conventional care regimens in older patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia (R/R AML)

Bibliografiske detaljer
Main Authors:	Dinardo, CD, Montesinos, P, Schuh, AC, Papayannidis, C, Vyas, P, Wei, AH, Zeidan, AM, Chen, C, Lord-Bessen, J, Yu, P, Shi, L, Guo, S, Bluemmert, I, Yu, X, Hasan, M, Martin Regueira, P, De Botton, S
Format:	Journal article
Sprog:	English
Udgivet:	American Society of Clinical Oncology 2022

Lignende værker

Health-related quality of life (HRQoL) during treatment with enasidenib (ENA) plus azacitidine (AZA) in patients with newly diagnosed mutant IDH2 (m IDH2) acute myeloid leukemia (AML) not eligible for intensive chemotherapy (IC)
af: DiNardo, CD, et al.
Udgivet: (2021)

Outcomes for patients with late-stage mutant-IDH2 (m IDH2) relapsed/refractory acute myeloid leukemia (R/R AML) treated with enasidenib vs other lower-intensity therapies in the randomized, phase 3 IDHentify Trial
af: DiNardo, CD, et al.
Udgivet: (2021)

Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML
af: Risueño, A, et al.
Udgivet: (2024)

AML-432 Overall survival (OS) by IDH2 mutant allele (R140 or R172) in patients with late-stage, mutant-IDH2 relapsed/refractory acute myeloid leukemia (AML) treated with enasidenib or conventional care regimens (CCR) in the randomized, open-label, Phase 3 IDHENTIFY Trial
af: DiNardo, CD, et al.
Udgivet: (2022)

Overall survival by IDH2 mutant allele (R140 or R172) in patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia treated with enasidenib or conventional care regimens in the phase 3 IDHENTIFY trial
af: De Botton, S, et al.
Udgivet: (2022)

Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial
af: de Botton, S, et al.
Udgivet: (2022)

A phase 3 study of Enasidenib (ENA) versus conventional care regimens (CCR) in older patients with late-stage mutant-IDH2 (MIDH2) relapsed/refractory acute myeloid leukemia (R/R AML)
af: Papayannidis, C, et al.
Udgivet: (2021)

Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial
af: DiNardo, CD, et al.
Udgivet: (2021)

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
af: Stein, EM, et al.
Udgivet: (2017)

Self-reported health-related quality of life (HRQoL) and factors affecting HRQoL among individuals with health insurance in Iran
af: Ali Kazemi Karyani, et al.
Udgivet: (2016-10-01)

Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib
af: Stein, EM, et al.
Udgivet: (2018)

Clonal heterogeneity of acute Myeloid Leukemia treated with the IDH2 inhibitor Enasidenib
af: Vyas, P, et al.
Udgivet: (2018)

The challenges of classical galactosemia: HRQoL in pediatric and adult patients
af: Merel E. Hermans, et al.
Udgivet: (2023-06-01)

Higher perceived HRQoL in Moroccan children with asthma and their parents
af: Monique Theodora Maria Veenstra-van Schie, et al.
Udgivet: (2015-05-01)

Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia
af: Keith W. Pratz, et al.
Udgivet: (2022-04-01)

Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia
af: Quek, L, et al.
Udgivet: (2017)

Molecular features associated with response to enasidenib plus azacitidine in newly diagnosed IDH2-mutated acute myeloid leukemia
af: Risueño, A, et al.
Udgivet: (2023)

HRQoL Evaluation of Pediatric Osteogenesis Imperfecta with Zoledronic Acid Therapy
af: Tri Wahyu Martanto, et al.
Udgivet: (2023-10-01)

Socioeconomic inequalities in HRQoL in England: an age-sex stratified analysis
af: Paul Schneider, et al.
Udgivet: (2022-08-01)

The association between diabetes mellitus and HRQoL of older people in Shanghai
af: Shiyin Tian, et al.
Udgivet: (2021-11-01)

Health-Related Quality of Life (HRQoL) of Patients with Tuberculosis: A Review
af: Sandul Yasobant, et al.
Udgivet: (2022-07-01)

The health gap and HRQoL inequalities in Greece before and during the economic crisis
af: John Yfantopoulos, et al.
Udgivet: (2023-06-01)

Cough suppression and HRQoL in adult people with cystic fibrosis: an unexplored correlation
af: Ute Niehammer, et al.
Udgivet: (2022-10-01)

Trait-Based Emotional Intelligence, Body Image Dissatisfaction, and HRQoL in Children
af: Olga Pollatos, et al.
Udgivet: (2020-01-01)

Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes
af: Lesley Ann Saketkoo, et al.
Udgivet: (2021-06-01)

Cosmetic Appeal, HRQoL, and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate Cancer
af: Ijeoma N. C. Chibuzo, et al.
Udgivet: (2021-01-01)

Factors affecting health-related quality of life (HRQoL) in Pakistani children with thalassemia
af: Narjis Batool, et al.
Udgivet: (2022-03-01)

Differential associations of sex and age with changes in HRQoL during outpatient cardiac rehabilitation
af: Lorenza L. S. Lanini, et al.
Udgivet: (2024-01-01)

Impact of smoking status on health-related quality of life (HRQoL) in cancer survivors
af: José Ignacio Nolazco, et al.
Udgivet: (2024-01-01)

Knowledge about Fibromyalgia in Fibromyalgia Patients and Its Relation to HRQoL and Physical Activity
af: María Mendoza-Muñoz, et al.
Udgivet: (2021-07-01)

Waist–Calf Circumference Ratio Is an Independent Risk Factor of HRQoL in Centenarians
af: Yang S, et al.
Udgivet: (2020-02-01)

Understanding the role of discriminative instruments in HRQoL research: can Ferguson's Delta help?
af: Wyrwich Kathleen W
Udgivet: (2008-10-01)

Impact, distress and HRQoL among Malaysian men and women with a mobility impairment
af: Omar Zaliha, et al.
Udgivet: (2006-12-01)

Measuring adolescents' HRQoL via self reports and parent proxy reports: an evaluation of the psychometric properties of both versions of the KINDL-R instrument
af: Ravens-Sieberer Ulrike, et al.
Udgivet: (2009-08-01)

The potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia
af: Bullinger Monika, et al.
Udgivet: (2021-05-01)

Gender disparities in health-related quality of life (HRQoL) in patients with cutaneous T-cell lymphoma
af: Christopher W. Chalaka, MD, et al.
Udgivet: (2023-06-01)

Predicting panel attrition in longitudinal HRQoL surveys during the COVID-19 pandemic in the US
af: Tianzhou Yu, et al.
Udgivet: (2022-07-01)

Weight associated factors in relation to health-related quality of life (HRQoL) in Iranian adolescents
af: Sara Jalali-Farahani, et al.
Udgivet: (2019-01-01)

Health-Related Quality of Life (HRQoL) in Idiopathic Inflammatory Myopathy: A Systematic Review.
af: Valérie Leclair, et al.
Udgivet: (2016-01-01)

Using self-determination theory to predict self-management and HRQoL in moderate-to-severe COPD
af: Liam Knox, et al.
Udgivet: (2021-01-01)